How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes

Tobacco Control

Volumn 26, Issue e1, 2017, Pages e49-e58

  Czoli, Christine D ^a   Fong, Geoffrey T ^a,b   Mays, Darren ^b   Hammond, David ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM;

ELECTRONIC CIGARETTE; HUMAN; PERCEPTION; PSYCHOLOGY; RISK; SMOKELESS TOBACCO; SMOKING; TOBACCO;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; NICOTINE; PERCEPTION; RISK; SMOKERS; SMOKING; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS; TOBACCO, SMOKELESS;

EID: 84987851111     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2016-053060     Document Type: Review

References (90)

1. Zeller M, Hatsukami D, the Strategic Dialogue on Tobacco Harm Reduction Group. The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tob Control 2009;18:324-32.
2. Hatsukami DK, Ebbert JO, Feuer RM, et al. Changing smokeless tobacco products. New tobacco-delivery systems. Am J Prev Med 2007;33:S368-78.
3. National Cancer Institute & Centers for Disease Control and Prevention. Smokeless tobacco and public health: a global perspective 2014. http://nccd.cdc.gov/gtssdata/Ancillary/Publications.aspx (accessed Jul 2015).
4. Levy DT, Mumford EA, Cummings KM, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev 2004;13:2035-42.
5. Breland A, Soule E, Lopez A, et al. Electronic cigarettes: what are they and what do they do? Ann N Y Acad Sci Published Online First: 15 Jan 2016. doi:10.1111/nyas.12977
6. Hajek P, Etter J-F, Benowitz N, et al. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014;109:1801-10.
7. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014;129:1972-86.
8. Stratton K, Shetty P, Wallace R, et al. Clearing the smoke: the science base for tobacco harm reduction-executive summary. Tob Control 2001;10:189-95.
9. Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes. JAMA 2013;310:685-6.
10. Romer D, Jamieson P. The role of perceived risk in starting and stopping smoking. In: Slovic P, ed. Smoking. Risk, perception, & policy. Thousand Oaks, CA: Sage Publications, Inc, 2001:64-80.
11. Hyland A, Li Q, Bauer JE, et al. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res 2004;6:S363-9.
12. Costello MJ, Logel C, Fong GT, et al. Perceived risk and quitting behaviors: results from the ITC 4-country survey. Am J Health Behav 2012;36:681-92.
13. Cengelli S, O'Loughlin J, Lauzon B, et al. A systematic review of longitudinal population-based studies on the predictors of smoking cessation in adolescent and youth adult smokers. Tob Control 2012;21:355-62.
14. Arens CR, White TL, Massengill N. Attitudinal factors protective against youth smoking: an integrative review. J Nurs Scholarsh 2014;46:167-75.
15. Kozlowski LT, Edwards BQ. "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product. Tob Control 2005;14:ii3-7.
16. Phillips CV, Wang C, Guenzel B. You might as well smoke; the misleading and harmful public message about smokeless tobacco. BMC Public Health 2005;5:31.
17. Kozlowski LT, O'Connor RJ. Apply federal research rules on deception to misleading health information: an example on smokeless tobacco and cigarettes. Public Health Rep 2003;118:187-92.
18. Kozlowski LT, Sweanor D. Withholding differential risk information on legal consumer nicotine/tobacco products: the public health ethics of health information quarantines. Int J Drug Policy 2016;32:17-23.
19. 111th Congress. Family Smoking Prevention and Tobacco Control Act 2009. http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf (accessed Jul 2015).
20. Bansal MA, Cummings KM, Hyland A, et al. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res 2004;6:S303-10.
21. Cummings KM, Hyland A, Giovino GA, et al. Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res 2004;6:S333-40.
22. Ambrose BK, Rostron BL, Johnson SE, et al. Perceptions of the relative harm of cigarettes and e-cigarettes among US youth. Am J Prev Med 2014;47:S53-60.
23. Amrock SM, Zakhar J, Zhou S, et al. Perception of e-cigarettes' harm and its correlation with use among U.S. adolescents. Nicotine Tob Res 2014;17:330-6.
24. Pearson JL, Richardson A, Niaura RS, et al. E-cigarette awareness, use, and harm perceptions in US adults. Am J Public Health 2012;102:1758-66.
25. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. New York, USA: Oxford University Press, 2008.
26. Grimshaw J. A knowledge synthesis chapter 2010. http://www.cihr-irsc.gc.ca/e/41382.html (accessed Jun 2015).
27. Schaefer SD, Henderson AH, Glover ED, et al. Patterns of use and incidence of smokeless tobacco consumption in school-age children. JAMA Otolaryngol Head Neck Surg 1985;111:639-42.
28. Prokhorov AV, Wetter DW, Padgett D, et al. Spit tobacco prevention and cessation counseling: statewide survey of health-care professionals and educators. Substance Use Misuse 2002;37:171-97.
29. Haddock CK, Lando H, Klesges RC, et al. Modified tobacco use and lifestyle change in risk-reducing beliefs about smoking. Am J Prev Med 2004;27:35-41.
30. O'Connor RJ, Hyland A, Giovino GA, et al. Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med 2005;29:85-90.
31. Klesges RC, Klesges LM, Vander Weg MW, et al. Characteristics of air force personnel who choose pharmacological aids for smoking cessation following an involuntary tobacco ban and tobacco control program. Health Psychol 2007;26:588-97.
32. O'Connor RJ, McNeill A, Borland R, et al. Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration. Nicotine Tob Res 2007;9:1033-42.
33. Smith SY, Curbow B, Stillman FA. Harm perception of nicotine products in college freshmen. Nicotine Tob Res 2007;9:977-82.
34. Tomar SL, Hatsukami DK. Perceived risk of harm from cigarettes or smokeless tobacco among U.S. high school seniors. Nicotine Tob Res 2007;9:1191-6.
35. Kaduri P, Kitua H, Mbatia J, et al. Smokeless tobacco use among adolescents in Ilala municipality, Tanzania. Tanzan J Health Res 2008;10:28-33.
36. Overland S, Hetland J, Aaro LE. Relative harm of snus and cigarettes: what do Norwegian adolescents say? Tob Control 2008;17:422-5.
37. Biener L, Bogen K. Receptivity to Taboka and Camel snus in a U.S. test market. Nicotine Tob Res 2009;11:1154-9.
38. Timberlake DS. Are smokers receptive to using smokeless tobacco as a substitute? Prev Med 2009;49:229-32.
39. Carpenter MJ, Gray KM. A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit. Nicotine Tob Res 2010;12:136-43.
40. Gartner CE, Jimenez-Soto EV, Borland R, et al. Are Australian smokers interested in using low-nitrosamine smokeless tobacco for harm reduction? Tob Control 2010;19:451-6.
41. Peiper N, Stone R, Van Zyl R, et al. University faculty perceptions of the health risks related to cigarettes and smokeless tobacco. Drug Alcohol Rev 2010;29:121-30.
42. Wikmans T, Ramstrom L. Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish snus. Tob Induc Dis 2010;8:9.
43. Callery WE, Hammond D, O'Connor RJ, et al. The appeal of smokeless tobacco products among young Canadian smokers: the impact of pictorial health warnings and relative risk messages. Nicotine Tob Res 2011;13:373-83.
44. McClave-Regan AK, Berkowitz J. Smokers who are also using smokeless tobacco products in the US: a national assessment of characteristics, behaviours and beliefs of 'dual users'. Tob Control 2011;20:239-42.
45. Smith JR, Novotny TE, Edland SD, et al. Determinants of hookah use among high school students. Nicotine Tob Res 2011;13:565-72.
46. Borland R, Li L, Cummings KM, et al. Effects of a fact sheet on beliefs about the harmfulness of alternative nicotine delivery systems compared with cigarettes. Harm Reduct J 2012;9:19.
47. Lund I, Scheffels J. Perceptions of the relative harmfulness of snus among Norwegian general practitioners and their effect on the tendency to recommend snus in smoking cessation. Nicotine Tob Res 2012;14:169-75.
48. Lund KE. Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes. Nicotine Tob Res 2012;14:1221-8.
49. Regan AK, Dube SR, Arrazola R. Smokeless and flavored tobacco products in the US: 2009 Styles Survey results. Am J Prev Med 2012;42:29-36.
50. Choi K, Forster J. Characteristics associated with awareness, perceptions, and use of electronic nicotine delivery systems among young US Midwestern adults. Am J Public Health 2013;103:556-61.
51. Popova L, Ling PM. Perceptions of relative risk of snus and cigarettes among US smokers. Am J Public Health 2013;103:e21-3.
52. Ayo-Yusuf OA, Agaku IT. Intention to switch to smokeless tobacco use among South African smokers: results from the 2007 South African Social Attitudes Survey. PLOS ONE 2014;9:e95553.
53. England LJ, Anderson BL, Tong VTK, et al. Screening practices and attitudes of obstetricians-gynecologists toward new and emerging tobacco products. Am J Obstet Gynecol 2014;211:e1-7.
54. Kaufman AR, Mays D, Koblitz AR, et al. Judgments, awareness, and the use of snus among adults in the United States. Nicotine Tob Res 2014;16:1404-8.
55. Lund I, Scheffels J. Perceptions of relative risk of disease and addiction from cigarettes and snus. Psychol Addict Behav 2014;28:367-75.
56. Richardson A, Pearson J, Xiao H, et al. Prevalence, harm perceptions, and reasons for using noncombustible tobacco products among current and former smokers. Am J Public Health 2014;104:1437-44.
57. Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics 2012;130:e879-85.
58. Adkison SE, O'Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: International Tobacco Control Four-Country Survey. Am J Prev Med 2013;44:207-15.
59. Dawkins L, Turner J, Roberts A, et al. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 2013;108:1115-25.
60. Dockrell M, Morrison R, Bauld L, et al. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013;15:1737-44.
61. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev 2013;32:133-40.
62. Li J, Bullen C, Newcombe R, et al. The use and acceptability of electronic cigarettes among New Zealand smokers. N Z Med J 2013;126:48-57.
63. Sutfin EL, McCoy TP, Morrell HER, et al. Electronic cigarette use by college students. Drug Alcohol Depend 2013;131:214-21.
64. Baeza-Loya S, Viswanath H, Carter A, et al. Perceptions about e-cigarette safety may lead to e-smoking during pregnancy. Bull Menninger Clin 2014;78:243-52.
65. Brown J, West R, Beard E, et al. Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers. Addict Behav 2014;39:1120-5.
66. Choi K, Forster JL. Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults. Am J Prev Med 2014;46:175-8.
67. Farsalinos KE, Romagna G, Tsiapras D, et al. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19, 000 consumers. Int J Environ Res Public Health 2014;11:4356-73.
68. Gallus S, Lugo A, Pacifici R, et al. E-cigarette awareness, use, and harm perceptions in Italy: a national representative survey. Nicotine Tob Res 2014;16:1541-8.
69. Harrell PT, Marquinez NS, Correa JB, et al. Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users ("vapers"). Nicotine Tob Res 2014;7:193-200.
70. Kandra KL, Ranney LM, Lee JGL, et al. Physicians' attitudes and use of e-cigarettes as cessation devices, North Carolina, 2013. PLOS ONE 2014;9:e103462.
71. Tan ASL, Bigman CA. E-cigarette awareness and perceived harmfulness: prevalence and associations with smoking-cessation outcomes. Am J Prev Med 2014;47:141-9.
72. Tucker JS, Shadel WG, Golinelli D, et al. Alternative tobacco product use and smoking cessation among homeless youth in Los Angeles county. Nicotine Tob Res 2014;16:1522-6.
73. Pokhrel P, Fagan P, Kehl L, et al. Receptivity to e-cigarette marketing, harm perceptions, and e-cigarette use. Am J Health Behav 2015;39:121-31.
74. Herbert R, Coleman T, Britton J. U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy. Nicotine Tob Res 2005;7:541-6.
75. Shiffman S, Ferguson SG, Rohay J, et al. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction 2008;103:1371-8.
76. Bobak A, Shiffman S, Gitchell JG, et al. Perceived safety of nicotine and the use of nicotine replacement products among current smokers in Great Britain: results from two national surveys. J Smok Cessat 2010;5:115-22.
77. Brewer NT, Chapman GB, Gibbons FX, et al. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol 2007;26:136-45.
78. Weinstein ND. What does it mean to understand a risk-evaluating risk comprehension. J Natl Cancer Inst Monographs 1999;25:15-20.
79. Sami M, Timberlake DS, Nelson R, et al. Smokers' perceptions of smokeless tobacco and harm reduction. J Public Health Policy 2012;33:188-201.
80. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract 2013;8:5.
81. Klapper JT. The effects of mass communication. New York, USA: Free Press, 1960.
82. Festinger L. A theory of cognitive dissonance. Illinois: Row and Peterson, 1957.
83. Fotuhi O, Fong GT, Zanna MP, et al. Patterns of cognitive dissonance-reducing beliefs among smokers: a longitudinal analysis from the International Tobacco Control (ITC) Four Country Survey. Tob Control 2013;22:52-8.
84. Besaratinia A, Tommasi S. Electronic cigarettes: the road ahead. Prev Med 2014;66:65-7.
85. Yamin C, Bitton A, Bates DW. E-cigarettes: a rapidly growing internet phenomenon. Ann Intern Med 2010;153:607-9.
86. Steinberg MB, Zimmerman MH, Delnevo CD, et al. E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J Gen Intern Med 2014;29:1444-50.
87. Clarke T. FDA approves sale of eight new Swedish Match snus products. Reuters, 2015. http://www.reuters.com/article/us-swedish-match-tobacco-usaidUSKCN0SZ2R420151110 (accessed Dec 2015).
88. Clarke T. FDA panel votes against label change to Swedish Match snus. Reuters, 2015. http://www.reuters.com/article/us-swedish-match-fdaidUSKBN0N11VP20150410 (accessed Dec 2015).
89. U.S. Department of Health and Human Services. The health consequences of smoking-50 years of progress. A report of the Surgeon General. 2014. http://www.surgeongeneral.gov/library/reports/50-years-of-progress/(accessed Jun 2015).
90. Karlsson P. Between a rock and a whirlpool? Measurement problems in assessing risk perceptions of illicit drug use. J Stud Alcohol Drugs 2011;28:149-57.